Armstrong Advisory Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.8K Hold
719
﹤0.01% 403
2026
Q1
$50.8K Hold
719
﹤0.01% 406
2025
Q4
$56.8K Hold
719
﹤0.01% 384
2025
Q3
$59.2K Buy
719
+387
+117% +$30.5K ﹤0.01% 374
2025
Q2
$26.7K Hold
332
﹤0.01% 496
2025
Q1
$27.2K Hold
332
﹤0.01% 465
2024
Q4
$27.2K Hold
332
﹤0.01% 465
2024
Q3
$27.4K Sell
332
-17
-5% -$1.27K ﹤0.01% 454
2024
Q2
$24.5K Sell
349
-66
-16% -$4.71K ﹤0.01% 463
2024
Q1
$27.4K Hold
415
﹤0.01% 425
2023
Q4
$27.4K Hold
415
﹤0.01% 425
2023
Q3
$26.1K Hold
415
﹤0.01% 435
2023
Q2
$23.5K Buy
415
+152
+58% +$8.44K ﹤0.01% 472
2023
Q1
$15.2K Hold
263
﹤0.01% 516
2022
Q4
$19K Buy
+263
New +$18.8K ﹤0.01% 498

Other funds holding MET

Armstrong Advisory Group's MET Position: Q2 2026 in Review

Armstrong Advisory Group held its MetLife (MET) position steady in Q2 2026 at 719 shares worth $60.8K. The position accounts for ﹤0.01% of the portfolio, ranked #403.

Armstrong Advisory Group first reported a position in MET in Q4 2022 and has held it in 15 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Armstrong Advisory Group held 719 shares of MetLife worth $60.8K as of Q2 2026.
  • Armstrong Advisory Group left its MetLife share count unchanged in Q2 2026.
  • MetLife made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #403 holding.
  • Armstrong Advisory Group first reported a position in MetLife in Q4 2022 and has held it in 15 quarters since.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.